SULT1B1 and neoplasm: Hence, ccr4 (15, 16), myoz2 (17), and clec3b (18, 19) are adverse prognosis biomarkers, while vwa5a (20) and sult1b1 (21) serve a tumor suppressor role in human solid tumors.